Core Viewpoint - The announcement by Qingdao Blue Biological Co., Ltd. reveals the completion of the acquisition of a 50% stake in Aidi Meng Blue Biological Technology (Shandong) Co., Ltd. from ADM Singapore, marking a transition from international collaboration to full ownership by the company [1] Group 1: Acquisition Details - The acquisition price for the 50% stake is set at 47 million RMB, and following the transaction, Aidi Meng Blue will become a wholly-owned subsidiary of Qingdao Blue Biological [1][8] - The joint venture, which began in 2021, faced several challenges including project suspension and liquidation, ultimately leading to Qingdao Blue Biological's decision to acquire full control [1][5] Group 2: Historical Context - The partnership with ADM Singapore started with a shareholder agreement in October 2021, where both parties agreed to a 50% ownership structure through capital increase [5] - Subsequent announcements indicated the establishment of a project for the research and industrialization of micro-ecological preparations, with a total investment of approximately 400 million RMB [6][9] Group 3: Financial Status of the Target Company - Aidi Meng Blue reported a net loss of 3.69 million RMB for 2025, with total liabilities of 338,700 RMB and a net asset value of approximately 119.11 million RMB [8] - The construction of the micro-ecological preparation project has not commenced, and the company currently lacks substantial operational activities [8] Group 4: Company Performance - Qingdao Blue Biological achieved a revenue of 1.32 billion RMB in 2024, reflecting a year-on-year growth of 10.16%, with a net profit of approximately 62.64 million RMB [9] - The company invested 118 million RMB in research and development, accounting for 8.95% of its revenue, indicating a strong commitment to innovation within the industry [9][10] Group 5: Industry Position - Qingdao Blue Biological is recognized as one of the early entrants in the micro-ecological preparation sector in China, leveraging its research and sales channel development to establish a competitive advantage [10] - The company has developed a comprehensive technical innovation system, including a high-throughput screening and identification technology platform for microbial strains, positioning it as a leader in the field [10]

（来源：千龙网） （作者单位：北京语言大学国际政治与传播学院） 与制度同构、安全绑定为前提的传统联盟模式不同，中国不强求合作对象在政治制度和价值体系上保持 一致，更不会以阵营站队作为合作前提，而是将重心放在发展和共生上。这与某些大国偏激蛮横、唯我 独尊的做法截然不同。长期以来，受国内政策约束和国际舆论压力的影响，很多国家的对华接触空间被 压缩，与中国关系"搁浅"成为一种被动接受的政治成本。但是当贸易与安全被高度工具化，这些国家不 得不思考，在安全依托和经济发展之间是否只有单一的选项。固然，这些国家选择中国，可能源自眼下 的困境，以及不堪忍受个别国家的盘剥打压，所谓"世界越乱，越需要中国。"但从长期来看，这些国家 顺应了追求自主发展的本能诉求，选择的是时代发展大势。这是中国以自身发展惠及全球，持续不断向 国际社会注入稳定性与确定性的必然结果。 "访华潮"对中国是一个机会窗口，对世界同样如此。无论什么时候，和平与发展都是各国人民的共同期 盼，开放合作、互利共赢永远是共同的愿景。推动国际秩序走向更具包容性的未来，更多热气腾腾的合 作佳话将成为世界繁荣稳定的生动注脚，让更多人明白"以人民之心为心、以天下之利为利"的东 ...